Clinical Trial Update: Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating terlipressin to reduce early postoperative acute kidney injury after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Liver Transplant Complications

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Acute Kidney Injury, Liver Transplant; Complications | Phase 4 | Status: UNKNOWN